VIRALCLEAR PHARMACEUTICALS, INC.

Profile

Company Names

VIRALCLEAR PHARMACEUTICALS, INC.
NEUROCLEAR TECHNOLOGIES, INC.

Addresses

54 WILTON ROAD, 2ND FLOOR, WESTPORT, CT 06880

Phone Numbers

(203) 409-5444
310-620-9320

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$14,857,620.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-05-20 
$10,751,250.00 
$25,000,000.00 
$14,248,750.00 
Equity 
3
2019-10-21 
$686,370.00 
$20,000,000.00 
$19,313,630.00 
Equity 
2
2019-09-05 
$160,000.00 
$160,000.00 
$0.00 
Equity 
1
2019-08-05 
$3,260,000.00 
$3,600,000.00 
$340,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVE 
 
CHAUSSY 
EXECUTIVE OFFICER
BIOSIG TECHNOLOGIES, INC.   |  NEUROCLEAR TECHNOLOGIES, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.
MICHAEL 
 
DOUGHERTY 
DIRECTOR
JELLI INC   |  VALUEAPPEAL, LLC   |  RECONROBOTICS, INC.   |  SYSTEMATECH TECHNICAL MANAGEMENT SERVICES, INC.   |  DELOITTE TOUCHE TOHMATSU SERVICES, INC.   |  DELOITTE TOUCHE TOHMATSU SERVICES, LLC   |  VIRALCLEAR PHARMACEUTICALS, INC.   |  BIOAFFINITY TECHNOLOGIES, INC.
NATASHA 
 
DRAPEAU 
EXECUTIVE OFFICER, DIRECTOR
NEUROCLEAR TECHNOLOGIES, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.
STEVEN 
 
KING 
EXECUTIVE OFFICER
NAPO PHARMACEUTICALS INC   |  INNOTAS   |  JAGUAR ANIMAL HEALTH, INC.   |  JAGUAR HEALTH, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.
KENNETH 
 
LONDONER 
EXECUTIVE OFFICER, DIRECTOR
BIOSIG TECHNOLOGIES, INC.   |  ALLIQUA, INC.   |  CHATAND INC   |  NEUROCLEAR TECHNOLOGIES, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.   |  BIOSIG AI SCIENCES, INC.
SAMUEL 
 
NAVARRO 
DIRECTOR
STRATA SKIN SCIENCES, INC.   |  BIOSIG TECHNOLOGIES, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.   |  PECA LABS, INC.
JEFFREY 
 
O-DONNELL 
DIRECTOR
EMBRELLA CARDIOVASCULAR INC   |  NITRIC BIOTHERAPEUTICS, INC.   |  INSYTE MEDICAL TECHNOLOGIES, INC.   |  BIOSIG TECHNOLOGIES, INC.   |  TRICE MEDICAL, INC.   |  NEUROCLEAR TECHNOLOGIES, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.   |  RUNWAY HEALTHCARE, LP   |  AERWAVE MEDICAL, INC.   |  ACCURE ACNE, INC.   |  ALGORITHM SCIENCES, INC.   |  MICRO INTERVENTIONAL DEVICES, INC.
DENNIS 
 
PURCELL 
DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  DYNOVA LABORATORIES INC   |  BRIDGE PHARMACEUTICALS, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.   |  SUMMUS GLOBAL, INC.
NICK 
 
SPRING 
EXECUTIVE OFFICER, DIRECTOR
VIRALCLEAR PHARMACEUTICALS, INC.
JEROME 
 
ZELDIS 
DIRECTOR
ALLIQUA, INC.   |  BIOSIG TECHNOLOGIES, INC.   |  KALYTERA THERAPEUTICS, INC.   |  ALLIQUA BIOMEDICAL, INC.   |  AIT THERAPEUTICS, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.   |  NEXGEL, INC.
ANTHONY 
 
ZOOK 
DIRECTOR
VIRALCLEAR PHARMACEUTICALS, INC.   |  BIOSIG TECHNOLOGIES, INC.   |  VOLTRON THERAPEUTICS, INC.   |  ALGORITHM SCIENCES, INC.   |  ADAPTIN BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-06-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-20 
2019-11-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-21 
2019-09-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-05 
2019-08-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037